AT&T Inc. (NYSE:T)is cutting dozens of Louisville jobs for service technicians due to a lack of need for installation and repair services, according to a company spokesperson. In a statement AT&T said, “Technology is changing rapidly and there are fewer jobs in parts of the industry that are declining and facing technology shifts, like our wireline business where these employees work.” The company went on to say they have nearly 900 employees working in the Louisville area.
AT&T Inc. (NYSE:T) shares tanked -0.06% to finally closed at $32.53 in last active session.
T’s distance from 20 day simple moving average is 1.45% and distance from 50-Day simple moving average is 2.85%.
Analyst’s mean target price for T is $33.80 while analysts mean recommendation is 2.30. Stock value has moved between $26.88 – 34.24 in last one year. Stock has got OUTPERFORM rating from 4 of Thomson Reuters analysts, 13 given HOLD rating to the stock and 2 given UNDERPERFORM rating. Analyst’s mean target price for T is $33.80 while analysts mean recommendation is 2.30.
AT&T Inc. (NYSE:T) yearly performance is 2.59% and net profit margin is 10.60%. Annual EPS Growth of past 5 years is -4.30%. The current share price indicates that stock is -5.16% away from its one year high and is moving 21.38% ahead of its 52-week low.
On 26 June 2018, Encana Corporation (NYSE:ECA) shares edged up 4.78% and ultimately finalized to $5.04 in last traded day. Stock has got OUTPERFORM rating from 16 of Thomson Reuters analysts, 9 given HOLD rating to the stock and 0 given UNDERPERFORM rating. Analyst’s mean target price for ECA is $10.54 while analysts mean recommendation is 2.20.
At the movement Taiwan Liposome Company, Ltd. (NASDAQ:TLC) is under coverage by number of analysts. Buy rating has been given by 0 analysts to the company stock whereas 0 given UNDERPERFORM rating to stock and 1 given HOLD rating. The consensus recommendation by Thomson Reuters analysts is hold and their mean rating for the stock is 3.00 on scale of 1-5. Analysts mean target price for Taiwan Liposome Company, Ltd. (NASDAQ:TLC) is $12.00 while their mean recommendation is 1.80 (1=Buy, 5=sell).
If we look at stock performance in last active day trading, we see that stock has moved remains unchanged to end the day at $5.40. The current share price indicate that stock is -50.91% away from its one year high and is moving 7.57% ahead of its 52-week low.